Israël - hébreu - Ministry of Health

bristol, myers squibb (israel) limited, israel - abatacept - תמיסה להזרקה - abatacept 125 mg/ml - abatacept - abatacept - orencia is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis. orencia may be used as monotherapy or concomitantly with disease-modifying antirheumatic drugs (dmards) other than tumor necrosis factor (tnf) antagonists.

Israël - hébreu - Ministry of Health

glaxo smith kline (israel) ltd - atovaquone; proguanil hydrochloride - טבליות מצופות פילם - atovaquone 62.5 mg; proguanil hydrochloride 25 mg - proguanil, combinations - proguanil, combinations - prevention of malaria: for the prophylaxis of p.falciparum malaria, including in areas where chloroquine resistance has been reported. treatment of malaria: for the treatment of acute, uncomplicated p.flaciparum malaria. malarone has been shown to be effective in regions where the drugs chloroquine, halofantrine, mefloquine, and modiaquine may have unacceptable failure rates, presumably due to drug resistance.malarone is recommended for pediatric patients who weigh over 11 kg.

Israël - hébreu - Ministry of Health

glaxo smith kline (israel) ltd - atovaquone; proguanil hydrochloride - טבליות מצופות פילם - atovaquone 250 mg; proguanil hydrochloride 100 mg - proguanil, combinations - proguanil, combinations - prevention of malaria: for the prophylaxis of p.falciparum malaria, including in areas where chloroquine resistance has been reported. treatment of malaria: for the treatment of acute, uncomplicated p.flaciparum malaria. malarone has been shown to be effective in regions where the drugs chloroquine, halofantrine, mefloquine, and modiaquine may have unacceptable failure rates, presumably due to drug resistance.

Israël - hébreu - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate; salmeterol as xinafoate - אבקה לשאיפה - fluticasone propionate 100 mcg; salmeterol as xinafoate 50 mcg - salmeterol and other drugs for obstructive airway diseases - salmeterol and other drugs for obstructive airway diseases - seretide is indicated in the regular treatment of severe and moderate reversible obstructive airways disease ( road) , including asthma in children and adults, where use of a combination (bronchodilator and inhaled corticosteroid) has been found to be appropriate.

Israël - hébreu - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate; salmeterol as xinafoate - אבקה לשאיפה - fluticasone propionate 500 mcg; salmeterol as xinafoate 50 mcg - salmeterol and other drugs for obstructive airway diseases - salmeterol and other drugs for obstructive airway diseases - seretide is indicated in the regular treatment of severe and moderate reversible obstructive airways disease ( road) , including asthma in children and adults, where use of a combination (bronchodilator and inhaled corticosteroid) has been found to be appropriate. extension of copd indication for seretide diskus:seretide is indicated for the symptomatic treatment of patients with copd, with a fev1 <60% predicted normal (pre-bronchodilator) and a history of repeated exacerbations, who have significant symptoms despite regular bronchodilator therapy.

Israël - hébreu - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate; salmeterol as xinafoate - אבקה לשאיפה - fluticasone propionate 250 mcg; salmeterol as xinafoate 50 mcg - salmeterol and other drugs for obstructive airway diseases - salmeterol and other drugs for obstructive airway diseases - seretide is indicated in the regular treatment of severe and moderate reversible obstructive airways disease ( road) , including asthma in children and adults, where use of a combination (bronchodilator and inhaled corticosteroid) has been found to be appropriate. extension of copd indication for seretide diskus:seretide is indicated for the symptomatic treatment of patients with copd, with a fev1 <60% predicted normal (pre-bronchodilator) and a history of repeated exacerbations, who have significant symptoms despite regular bronchodilator therapy.

Israël - hébreu - Ministry of Health

abic marketing ltd, israel - beclometasone dipropionate - משאף - beclometasone dipropionate 50 mcg/dose - beclometasone - beclometasone - prophylaxis and treatment of bronchial asthma in adults and children 5 years of age and obove.

Israël - hébreu - Ministry of Health

teva israel ltd - beclometasone dipropionate - משאף - beclometasone dipropionate 100 mcg/dose - beclometasone - beclometasone - prophylaxis and treatment of bronchial asthma in adults and children 5 years of age and obove.

Israël - hébreu - Ministry of Health

rekah pharmaceutical industry ltd, israel - bacitracin; neomycin as sulfate; polymyxin b sulfate - משחה לעין - bacitracin 400 u/g; polymyxin b sulfate 5000 u/g; neomycin as sulfate 5 mg/g - antibiotics in combination with other drugs - antibiotics in combination with other drugs - short term treatment of superficial external ocular infections caused by organisms susceptible to one or more of the antibiotics contained therein.

Israël - hébreu - Ministry of Health

equashield medical ltd - אחות - the equashield™ drug reconstitution and transfer system is a contained system to be used by pharmacists or other health care professionals to prepare drugs, including cytotoxic drugs, for intravenous infusion or injection